People with comorbidities were included in the priority groups to receive the bivalent vaccine against covid-19. The decision was published this Friday (31) by the Ministry of Health. According to the technical note, the inclusion was made due to the availability of immunizer doses and is based on guidelines from the World Health Organization (WHO).
The list of comorbidities includes:
– diabetes mellitus
– severe chronic lung diseases
– resistant hypertension
– stage 3 high blood pressure
– stage 1 and 2 hypertension with target organ damage
– cardiac insufficiency
– corpulmonary and pulmonary hypertension
– hypertensive heart disease
– coronary syndromes
– valvopathies
– cardiomyopathies and pericardiopathies
– diseases of the aorta, great vessels and arteriovenous fistulas
– cardiac arrhythmias
– congenital heart disease in adults
– prosthetic valves and implanted cardiac devices
– chronic neurological diseases and muscular dystrophies
– chronic kidney disease
– severe haemoglobinopathies and splenic dysfunctions
– morbid obesity
– Down syndrome and other genetic syndromes
– chronic liver disease
Anyone aged between 12 and 59 who has any of the listed conditions and who has already taken the two boosters against covid-19 can receive the bivalent. It is not necessary to prove comorbidity.
“It should be noted that, for this group, there will be no requirement to prove the situation of comorbidity, with self-declared comorbidity being sufficient for vaccination”, informs a note from the Ministry of Health.
